281 results on '"Koca, Süleyman Serdar"'
Search Results
2. Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?
3. Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
4. Budd–Chiari syndrome in Behçet’s disease: a retrospective multicenter study
5. A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting: results from TURKBIO registry
6. INTRALESIONAL STEROID THERAPY IN PATIENTS WITH IDIOPATHIC GRANULOMATOUS MASTITIS
7. IDIOPATHIC GRANULOMATOUS MASTITIS: MULTICENTER STUDY
8. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients
9. Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry
10. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients.
11. The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis
12. SCLERODERMA RENAL CRISIS
13. The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis.
14. The Efficacy and Safety of CT-P13 as First-line and Subsequent-line Therapy in Patients with Ankylosing Spondylitis: Real-life Data from TURKBIO Cohort
15. Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort
16. Effects of acute aerobic exercise on brain-derived neurotrophic factor level in rheumatoid arthritis patients.
17. Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis
18. Training Course Results of the Assessment of Modified Rodnan Skin Score in Scleroderma
19. BIYOLOJIK AJAN TEDAVISI ALAN SPONDILOARTRIT HASTALARININ COVID-19AŞILAMASI: GERÇEK YAŞAM VERISI
20. Sistemik sklerozis ilişkili dijital ülserin tanımı ve tedavisinde Türkiye Romatoloji Derneği ulusal önerileri
21. Sleep Quality Is Related to Disease Activity in Patients With Ankylosing Spondylitis: A Polysomnographic Study
22. R–R interval variation and sympathetic skin response in systemic lupus erythematosus
23. The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database.
24. The inhibition of Src kinase suppresses the production of matrix metalloproteinases in from synovial fibroblasts and inhibits MAPK and STATs pathways
25. Wnt signaling pathway activities may be altered in primary Sjogren’s syndrome
26. Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic
27. Budd–Chiari syndrome in Behçet’s disease: a retrospective multicenter study
28. Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results
29. Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data
30. Sonoelastrographic finding of Achilles tendon in patients with ankylosing spondylitis and acromegaly.
31. Physical activity and psychosomatic status in patients with Behçet’s disease during coronavirus disease pandemic.
32. The main differences between connective tissue diseases-associated interstitial lung disease and idiopathic pulmonary fibrosis
33. A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry.
34. Serum netrin-1 and netrin receptor levels in fibromyalgia and osteoarthritis.
35. Sekukinumab tedavisi alan ankilozan spondilitli hastalarda tedavi yanıtları ve ilaçta sağkalım oranları:gerçek yaşam verileri Türkbio veri tabanı çalışması
36. Are There Any Differencies Between Adult-Onset Rheumatoid Arthritis and Late-Onset Rheumatoid Arthritis Patients in Terms of Use of Biological Drugs and Drug Retention Rate?
37. Sekukinumab tedavisi alan nonradyografik aksiyal spondilartrit ve ankilozan spondilit tanılı hastalarda tedavi yanıtı üzerine obezitenin etkisinin değerlendirilmesi; Türkbio veri tabanı çalışması
38. Geç Başlangıçlı Ankilozan Spondilit Hastalarında Anti-TNF Alfa Tedavisinin Erken Yaşta Semptomları Başlayanlara Göre Etkinliği ve Güvenliği TÜRKBİO Veritabanı
39. Komorbidite varlığı, aksiyal spondiloartritte ilk TNFitedavideki kalımı ve tedavinin etkinliğini azaltmaktadır:TÜRK-BİO verileri
40. Sekukinumab Tedavisi Akan Nonradyografik Aksiyal Spondiloartrit ve Ankilozan Spondilit Tanılı Hastaların Demografik-Klinik Özellikleri ve Tedavi Yanıtı Üzerine Obezitenin Etkisinin Değerlendirilmesi: TURKBIO Veritabanı Çalışması
41. The Efficacy and Safety of Anti-TNF Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset The Data from TURKBIO Registry
42. Gelişmiş RA tedavisi almakta olup başka bir gelişmiş RA tedavisine geçen veya gelişmiş RA tedavisi-naif hastaların temel özellikleri ve tedavi yöntemi tercihlerinin ara analizi: Çok Merkezli, prospektif, gözlemsel çalışma
43. Komorbidite varlığı, aksiyel spondiloartritte ilk TNFi tedavideki kalımı ve tedavinin etkinliğini azaltmaktadır: TÜRK-BİO verileri
44. The Efficacy and Safety of Anti-TNF alpha Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset; The Data from TURKBIO Registry
45. Mango ginger (curcuma amada) inhibits collagen-induced arthritis by modulating inflammatory cytokine levels in rats
46. Tuberculin Skin Test in Spondyloarthritis: Overestimated if Rheumatoid Arthritis Guidelines for Latent Tuberculosis Are Used?
47. Complementary alternative medicine in rheumatic diseases: Causes, choices, and outcomes according to patients.
48. Subcutaneous and intravenous applications of abatacept therapy used in the treatment of rheumatoid arthritis show similar efficacy
49. Gastrointestinal vasculitis due to systemic lupus erythematosus treated with rituximab: a case report
50. Sistemik skleroz hastalarında genişletilmiş otoantikor profili ve klinik özelliklerle ilişkisi: Dört yıllık takip verileri.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.